Anna Postolova, Megan L Troxell, Irene L Wapnir, Mark C Genovese
The Journal of rheumatology 2020 Jun 01Idiopathic granulomatous mastitis (IGM) is a disfiguring inflammatory breast disease without effective treatment. We report the largest IGM cohort treated with methotrexate (MTX) monotherapy. Chart review was performed on patients evaluated by the Stanford Immunology and Rheumatology Clinic, with histopathologically established IGM treated with MTX, and at least 1 followup appointment. Nineteen female patients with a mean age of 33.5 years were identified. Most failed treatment with antibiotics, prednisone, and surgical intervention. By 15 months of treatment with MTX, 94% had disease improvement and 75% achieved disease remission. MTX monotherapy is an effective treatment for IGM.
Anna Postolova, Megan L Troxell, Irene L Wapnir, Mark C Genovese. Methotrexate in the Treatment of Idiopathic Granulomatous Mastitis. The Journal of rheumatology. 2020 Jun 01;47(6):924-927
Mesh Tags
Substances
PMID: 31203215
View Full Text